Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × NETWORK × Plasmablastic Lymphoma × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Plasmablastic Lymphoma 1 Neoplasms 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

prednylidene 1 deltacortene 1 daratumumab 1 Vincristine 1 Prednisone 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

AIDS Malignancy Consortium

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡